These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9803879)

  • 1. Homing mechanisms in the biology of multiple myeloma.
    Van Camp B; Van Riet I
    Verh K Acad Geneeskd Belg; 1998; 60(3):163-94. PubMed ID: 9803879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homing mechanisms in the etiopathogenesis of multiple myeloma.
    Van Riet I; Bakkus M; De Greef C; Faid L; Van Camp B
    Stem Cells; 1995 Aug; 13 Suppl 2():22-7. PubMed ID: 8520507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homing mechanisms of myeloma cells.
    Van Riet I
    Pathol Biol (Paris); 1999 Feb; 47(2):98-108. PubMed ID: 10192876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement of soluble factors produced by bone marrow stromal cells on the growth of novel established human myeloma cell line.
    Aikawa S; Hatta Y; Tanaka M; Kaneita Y; Yasukawa K; Sawada U; Horie T; Tsuboi I; Aizawa S
    Int J Oncol; 2003 Mar; 22(3):631-7. PubMed ID: 12579318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant (MM5.2).
    Van Riet I; De Greef C; Aharchi F; Woischwill C; De Waele M; Bakkus M; Lacor P; Schots R; Van Camp B
    Leukemia; 1997 Feb; 11(2):284-93. PubMed ID: 9009094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin alpha4beta1 involvement in stromal cell-derived factor-1alpha-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion.
    Parmo-Cabañas M; Bartolomé RA; Wright N; Hidalgo A; Drager AM; Teixidó J
    Exp Cell Res; 2004 Apr; 294(2):571-80. PubMed ID: 15023543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
    Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
    Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migration, adhesion and differentiation of malignant plasma cells in the 5T murine model of myeloma.
    Asosingh K
    Verh K Acad Geneeskd Belg; 2003; 65(2):127-34. PubMed ID: 12870183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro growth of human multiple myeloma: implications for biology and therapy.
    Caligaris-Cappio F; Gregoretti MG; Ghia P; Bergui L
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):257-71. PubMed ID: 1582973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules.
    Pilarski LM; Jensen GS
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):297-322. PubMed ID: 1533857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The mechanisms of myeloma cell growth].
    Shimizu S
    Nihon Rinsho; 1995 Mar; 53(3):557-63. PubMed ID: 7699885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of interleukin 6 in multiple myeloma and bone marrow stromal cells.
    Chauhan D; Uchiyama H; Urashima M; Yamamoto K; Anderson KC
    Stem Cells; 1995 Aug; 13 Suppl 2():35-9. PubMed ID: 8520509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of multiple myeloma cell growth].
    Simizu S; Konda S
    Rinsho Ketsueki; 1993 Apr; 34(4):418-22. PubMed ID: 8510327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunology of myeloma].
    Bataille R; Klein B; Rossi JF
    Nouv Rev Fr Hematol (1978); 1987; 29(4):255-64. PubMed ID: 3320951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key differentiation steps in normal B cells and in myeloma cells.
    Zubler RH
    Semin Hematol; 1997 Jan; 34(1 Suppl 1):13-22. PubMed ID: 9122741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients.
    Cassel A; Leibovitz N; Hornstein L; Quitt M; Aghai E
    Exp Hematol; 1990 Dec; 18(11):1171-3. PubMed ID: 2226677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloma cells (5TMM) and their interactions with the marrow microenvironment.
    Menu E; Asosingh K; Van Riet I; Croucher P; Van Camp B; Vanderkerken K
    Blood Cells Mol Dis; 2004; 33(2):111-9. PubMed ID: 15315788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.